Shes been teaching, educating, working with patients and professionals for more than two decades
By activating GLP-1 receptors in these regions, semaglutide influences the balance between orexigenic (appetite-stimulating) and anorexigenic (appetite-suppressing) neuropeptides
However, Eli Lilly's existing GLP-1 franchise generated $36.5 billion in 2025, analysts project retatrutide could add $15+ billion annually, and the combined obesity drug market is projected to reach $101 billion in peak annual sales
Pricing, promotional offers, pharmacy availability, dosage, and eligibility may change
This weight reduction was not merely cosmetic
Will I keep the weight off after stopping